Talee Bio Founder Dr. Michael Welsh Wins Warren Alpert Foundation Prize
TaleeBio founder Dr. Michael Welsh was awarded the 2018 Warren Alpert Foundation Prize for his transformative discoveries in cystic fibrosis. In association with Harvard Medical School, the Warran Alpert Foundation recognizes leading researchers whose work has improved the understanding, prevention, treatment or cure for human disease.
TaleeBio Wins 2018 PACT Enterprise Award for Best Healthcare Startup
Talee Bio wins 2018 PACT Enterprise Award for best healthcare startup. The 25th annual gathering celebrated leaders in Philadelphia’s healthcare and space.
https://www.phillymag.com/business/2018/05/10/pact-enterprise-awards/
Tmunity raises $135M series A to drive forward T-cell immunotherapy pipeline
MHV portfolio company, Tmunity, raises large A round to progress a promising pipeline of T-cell immunotherapies.
See coverage in FierceBiotech:
